SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Sepracor-Looks very promising -- Ignore unavailable to you. Want to Upgrade?

To: Thomas M. who wrote (2802)5/17/1999 2:57:00 PM
From: Biomaven  Read Replies (1) | Respond to of 10280
 
Tom,

One more item from the CC:

Someone asked about the Allegra interference - reply was it should be determined by year end, but hinted (at least by my reading) at a settlement that would also include resolution of European sales of Allegra (HMR is selling without a license in Europe, is contesting SEPR's European patent, and SEPR has brought infringement proceedings against HMR in the UK).

So my guess is that we'll see a settlement with HMR.

Peter


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News